Radiodermatitis Market Size 2022-27, Top Companies Overview, Report, Share, Growth, Industry Trends and Forecast Analysis
According to the latest report by IMARC Group, titled " Global Radiodermatitis Market Size, Share, Industry Trends, Growth, Opportunity and Forecast 2022-2027 ", the global radiodermatitis market reached a value of US$ 464.4 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 579.5 Million by 2027, exhibiting a CAGR of 3.60% during 2022-2027. Radiation dermatitis, or radiodermatitis, is a skin condition caused on account of the therapy utilized for the treatment of cancer. It commonly occurs as a side effect after interventional radiology in patients with cancers of the lungs, breast, skin, neck, head, or perineum region. Commonly used products to treat radiodermatitis include corticosteroids, hydrophilic creams, topical antibiotics, hydrogel, hydrocolloid dressings, silicone-coated, silver-leaf dressings, oral analgesics, anti-inflammatory agents, etc. These treatments aid in reducing discomfort, minimizing pain, preventing interruption...